FA
Insider
Forbion Capital Fund IV Cooperatief U.A.
10% ownerForbion Capital Fund IV Cooperatief U.A. (10% owner) filed 2 Form 4 reports as a reporting entity in the past 24 months (0 purchases, 2 sales), most often in NewAmsterdam Pharma Company N.V. (NAMS). The largest single filing was $1.9M of NAMS (74,910 sh across 2 lots, as filed), executed Dec 26 2024.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.2M
shares × price, as filed
Last traded
Dec 27 2024
Filed Dec 30 2024
Median ADV $32.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 24 months
Most traded names
NAMSRecent filings
NAMSSALE
NewAmsterdam Pharma Company N.V.
View filing →
$1.9M74,910 sh across 2 lots
Exec Dec 26 2024
Filed Dec 30 2024 · 5:30 PM ET NAMSSALE NewAmsterdam Pharma Company N.V. View filing → $246K
9,832 sh × $25.01
Exec Nov 14 2024
Filed Nov 15 2024 · 5:30 PM ET